Ring calls on Singapore research agencies for gene therapy pact
06 Nov 2024 //
FIERCE BIOTECH
Ring Therapeutics Announces A*STAR & SERI Partnerships in Singapore
04 Nov 2024 //
GLOBENEWSWIRE
Ring Therapeutics Presents Preclinical Data On Anellogy™ Platform
22 Oct 2024 //
GLOBENEWSWIRE
Ring Therapeutics To Present Keynote At SPICA Conference
08 Oct 2024 //
GLOBENEWSWIRE
Ring Therapeutics Anellogy Data At ASGCT 2024
07 May 2024 //
GLOBENEWSWIRE
Ring Therapeutics ASGCT 2024 Presentations
22 Apr 2024 //
GLOBENEWSWIRE
Ring Publishes a Novel Gene Delivery Platform Based on the Human Anellovirus
01 Apr 2024 //
GLOBENEWSWIRE
Ring Therapeutics Presents New Data on Anellogy Platform
24 Oct 2023 //
GLOBENEWSWIRE
Ring Therapeutics Announces Two Late Breaker Presentations at Conference
26 Sep 2023 //
GLOBENEWSWIRE
Ring Announces Appointment of Konstantin Konstantinov as CTO
07 Jun 2023 //
GLOBENEWSWIRE
Ring Therapeutics Strengthens Executive Team Christopher McNulty as CFO
01 May 2023 //
GLOBENEWSWIRE
Ring Therapeutics Raises $86.5 Million in Series C Funding
09 Mar 2023 //
GLOBENEWSWIRE
Ring Announces Appointment of Industry Veteran Christopher Wright as CMO
30 Jan 2023 //
GLOBENEWSWIRE
Ring Therapeutics Announces Issuance of U.S. Patent for its Anellovector™
20 Sep 2022 //
GLOBENEWSWIRE
Ring Therapeutics Announces 3 Presentations at 41st Annual Meeting of the ASV
18 Jul 2022 //
GLOBENEWSWIRE
Ring Tx Publishes First Human Anellovirus Structure with Key Insights
06 Jul 2022 //
GLOBENEWSWIRE
Ring Therapeutics Announces Two Presentations at the Upcoming 25th ASGCT
03 May 2022 //
GLOBENEWSWIRE
Ring Therapeutics Announces Publication on Synthesized Human Anelloviruses
02 May 2022 //
GLOBENEWSWIRE
Ring Tx Publishes Highlighting Immune Favorability of Commensal Anelloviruses
31 Mar 2022 //
GLOBENEWSWIRE
Ring Tx says the Appointment of Industry Leaders to its Board of Directors
17 Mar 2022 //
GLOBENEWSWIRE